Article | 2026 Clinical Trials at the Summit
OLN-324 Shows Extended Drying in DME
In the JADE trial, the investigational bispecific agent demonstrated a faster and more durable anatomic response than faricimab. Phase 3 trials are expected to begin later this year.







